Business Description
Ascletis Pharma is a Hong Kong-based biotechnology company founded in 2013 that develops, manufactures, and sells medicines primarily in Mainland China. Its current products focus on treating Hepatitis C, and its growing pipeline targets a wide range of conditions including HIV, COVID-19, liver disease, obesity, acne, and certain cancers. The company combines commercial sales with an active drug development program spanning both infectious diseases and chronic conditions.
